Concepedia

Iris Nagelmeier

IN

7

Publications

803

Citations

7

H-Index

2009

Active since

Affiliations

University of Göttingen(Current)

University of Milan

European Institute of Oncology

Roche Pharma AG (Germany)

Iris Nagelmeier is an author at University of Göttingen specializing in medicine, oncology, and radiation oncology.

Top concepts

Publications per year

2009–2022

7

Publications

7

HER2 diagnostics in gastric cancer—guideline validation and development of standardized immunohistochemical testing

Josef Rüschoff, Manfred Dietel, Gustavo Baretton et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2010 · 486 citations · Full text

EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer

Marileila Varella‐Garcia, Joachim Diebold, David A. Eberhard et al. · Journal of Clinical Pathology · 2009 · 117 citations · Full text

, , +20

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status

Josef Rüschoff, Michael Friedrich, Iris Nagelmeier et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2022 · 78 citations · Full text

Impact of updated HER2 testing guidelines in breast cancer—re-evaluation of HERA trial fluorescence in situ hybridization data

Andreas H. Scheel, Iris Nagelmeier, Hans‐Ulrich Schildhaus et al. · Modern Pathology · 2015 · 60 citations · Full text

, , +10

HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer

Hanna Styczen, Iris Nagelmeier, Tim Beißbarth et al. · Oncotarget · 2015 · 29 citations · Full text

Rows per page

1–5 of 7